Reference : Outcome of Patients with Hepatocellular Carcinoma Listed for Liver Transplantation Wi...
Scientific journals : Article
Human health sciences : Surgery
Human health sciences : Oncology
Human health sciences : Gastroenterology & hepatology
Outcome of Patients with Hepatocellular Carcinoma Listed for Liver Transplantation Within the Eurotransplant Allocation System
Adler, Michael [> >]
De Pauw, Filip [> >]
Vereerstraeten, Pierre [> >]
Fancello, Agnese [> >]
Lerut, Jan [> >]
Starkel, Peter [> >]
Van Vlierberghe, Hans [> >]
Troisi, Roberto [> >]
Donckier, Vincent [> >]
Detry, Olivier mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
Delwaide, Jean mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gastro-Entérologie-Hépatologie >]
Michielsen, Pieter [> >]
Chapelle, Thierry [> >]
Pirenne, Jacques [> >]
Nevens, Frederik [> >]
Liver Transplantation
Yes (verified by ORBi)
New York
[en] hepatocarcinoma ; results ; liver transplantation
[en] Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation, the rules governing priority and access to the waiting list are not well defined. Patient- and tumor-related variables were evaluated in 226 patients listed primarily for HCC in Belgium, a region where the allocation system is patient-driven, priority being given to sicker patients, based on the Child-Turcotte-Pugh (CTP) score. Intention-to-treat and posttransplantation survival rates at 4 years were 56.5 and 66%, respectively, and overall HCC recurrence rate was 10%. The most significant predictors of failure to receive a transplant in due time were baseline CTP score equal to or above 9 (relative risk [RR] 4.1; confidence interval [CI]: 1.7-9.9) and alpha fetoprotein above 100 ng/mL (RR 3.0; CI: 1.2-7.1). Independent predictors of posttransplantation mortality were age equal to or above 50 years (RR 2.5; CI: 1.0-3.7) and United Network for Organ Sharing pathological tumor nodule metastasis above the Milan criteria (RR 2.1; CI: 1.0-5.9). Predictors of recurrence (10%) were _ fetoprotein above 100 ng/mL (RR 3.2; CI:1.1-10) and vascular involvement of the tumor on the explant (RR 3.6; CI: 1.1-11.3). Assessing the value of the pretransplantation staging by imaging compared to explant pathology revealed 34% accuracy, absence of carcinoma in 8.3%, overstaging in 36.2%, and understaging in 10.4%. Allocation rules for HCC should consider not only tumor characteristics but also the degree of liver impairment. Patients older than 50 years with a stage above the Milan criteria at transplantation have a poorer prognosis after transplantation.
Professionals ; Students ; General public

File(s) associated to this reference

Fulltext file(s):

Open access
Liver Tx.2008.pdfNo commentaryPublisher postprint155.08 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.